Keyphrases
Neurofilament Light (NF-L)
100%
Multiple Sclerosis
100%
Cognitive Performance
100%
Epstein-Barr Virus
100%
Vitamin D
100%
Confidence Interval
75%
Epstein-Barr nuclear Antigen
75%
Paced Auditory Serial Addition Test (PASAT)
75%
Immunoglobulin G
50%
Non-smokers
50%
25-hydroxyvitamin D (25OHD)
50%
Smokers
50%
Clinical Trials
25%
Chain Level
25%
Body Mass Index
25%
Initial Treatment
25%
20-High
25%
Linear Regression Model
25%
Cognitive Function
25%
Non-associated
25%
Antibody Concentration
25%
Epstein-Barr Virus-positive
25%
Logistic Regression Model
25%
Treatment Allocation
25%
Test Performance
25%
Steroid Treatment
25%
G-levels
25%
Aging Treatment
25%
Heavy Smokers
25%
Cotinine
25%
Clinically Isolated Syndrome
25%
Cognitive Status
25%
Neuronal Integrity
25%
T2 Lesions
25%
Betaseron
25%
Smoking Biomarker
25%
Serum 25-hydroxyvitamin D [25(OH)D]
25%
Serum Neurofilament Light Chain
25%
Clinical Onset
25%
Betaferon
25%
Neuroaxonal Injury
25%
Medicine and Dentistry
Multiple Sclerosis
100%
Epstein Barr Virus
100%
Neurofilament
100%
Vitamin D
100%
Light Chain
100%
Paced Auditory Serial Addition Test
60%
Epstein Barr Virus Antigen 1
60%
Biological Marker
40%
Interferon Beta Serine
40%
Immunoglobulin G
40%
Clinical Trial
20%
Clinically Isolated Syndrome
20%
Logistic Regression Analysis
20%
Linear Regression Analysis
20%
Body Mass Index
20%
Virus Antibody
20%
Steroid Treatment
20%
25 Hydroxyvitamin D
20%
Cotinine
20%
Neuroscience
Neurofilament Light Chain
100%
Multiple Sclerosis
100%
Vitamin D
100%
Epstein-Barr Virus
100%
Epstein-Barr Virus Nuclear Antigen 1
60%
Paced Auditory Serial Addition Test
60%
Immunoglobulin G
40%
Interferon Beta 1b
40%
Cognitive Function
20%
Body Mass Index
20%
25 Hydroxyvitamin D
20%
Virus Antibody
20%
Cotinine
20%
Demyelinating Disease
20%
Pharmacology, Toxicology and Pharmaceutical Science
Epstein-Barr Virus
100%
Vitamin D
100%
Multiple Sclerosis
100%
Epstein-Barr Virus Nuclear Antigen 1
75%
Biological Marker
50%
Interferon Beta Serine
50%
Immunoglobulin G
50%
Clinical Trial
25%
Steroid Treatment
25%
Virus Antibody
25%
25 Hydroxyvitamin D
25%
Cotinine
25%
Demyelinating Disease
25%
Immunology and Microbiology
Multiple Sclerosis
100%
Light Chain
100%
Neurofilament
100%
Epstein Barr Virus
100%
Epstein-Barr Virus Nuclear Antigen 1
60%
Immunoglobulin G
40%
Interferon Beta 1b
40%
Body Mass
20%
Antibody Blood Level
20%
Virus Antibody
20%
Clinically Isolated Syndrome
20%
Biochemistry, Genetics and Molecular Biology
Light Chain
100%
Epstein Barr Virus
100%
Vitamin D
100%
Neurofilament Light
100%
Epstein-Barr Virus Nuclear Antigen 1
60%
Immunoglobulin G
40%
Interferon Beta 1b
40%
Clinical Trial
20%
Body Mass
20%
Antibody Blood Level
20%
Cotinine
20%